Effects of rosiglitazone treatment on insulin resistance and TNF-alpha levels in patients with chronic kidney disease: a prospective study
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.16, no.11, pp.1519-1524, 2012 (SCI-Expanded)
- Publication Type: Article / Article
- Volume: 16 Issue: 11
- Publication Date: 2012
- Journal Name: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1519-1524
- Keywords: Rosiglitazone, Insulin resistance, Chronic kidney disease, TNF-alpha, NECROSIS-FACTOR-ALPHA, C-REACTIVE PROTEIN, HOMEOSTASIS MODEL ASSESSMENT, BLOOD-PRESSURE VARIABILITY, WAIST CIRCUMFERENCE, INFLAMMATION, ASSOCIATION, PREVALENCE, RISK, SENSITIVITY
- Akdeniz University Affiliated: No
Abstract
AIM: The aim of the study was to investigate the effects of rosiglitazone treatment on insulin resistance (IR) and tumor necrosis factor-alpha (TNF-alpha) levels in nondiabetic chronic kidney disease (CKD) patients with IR.